Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Oogenesis01:22

Oogenesis

Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Folliculogenesis01:20

Folliculogenesis

Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Proceedings of the 1st European Ovary Workshop (EOW 2025) Lagos, Portugal - February 17-20, 2025.

Molecular human reproduction·2026
Same author

Cost-effectiveness of infertility treatment pathways in PCOS: where does oocyte in-vitro maturation fit?

Journal of assisted reproduction and genetics·2026
Same author

Can oral dydrogesterone mitigate adverse outcomes with low progesterone on transfer day in natural-cycle frozen embryo transfer?

Reproductive biomedicine online·2026
Same author

Dydrogesterone versus micronized vaginal progesterone for luteal phase support in artificial cycle frozen embryo transfer (REMODEL): a pilot prospective randomized controlled trial.

Frontiers in endocrinology·2026
Same author

Managing suspected endometrial polyps during IVF/ICSI stimulation: retrospective cohort study of fresh versus freeze-all strategies.

Reproductive biomedicine online·2026
Same author

Developing anti-Müllerian hormone as an ovarian reserve biomarker.

Molecular human reproduction·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jun 10, 2026

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

Insuficiencia ovárica primaria La insuficiencia ovárica primaria es una insuficiencia ovárica primaria.

Michel De Vos1, Paul Devroey, Bart C J M Fauser

  • 1Centre for Reproductive Medicine, UZ Brussel, Brussels, Belgium. mdevos@uzbrussel.be

Lancet (London, England)
|August 17, 2010
PubMed
Resumen
Este resumen es generado por máquina.

La insuficiencia ovárica primaria (POI) es una disfunción ovárica debida a causas ováricas, que a menudo conduce al agotamiento prematuro del folículo. El diagnóstico implica un nivel elevado de FSH y un nivel bajo de estradiol, lo que afecta la salud reproductiva y la fertilidad.

Más Videos Relacionados

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Videos de Experimentos Relacionados

Last Updated: Jun 10, 2026

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Área de la Ciencia:

  • Endocrinología Reproductiva y Reproducción.
  • Genética La genética.
  • Oncología Oncología.

Sus antecedentes:

  • La insuficiencia ovárica primaria (IOP) es una condición caracterizada por la incapacidad del ovario para funcionar normalmente.
  • A menudo resulta del agotamiento prematuro de la reserva del folículo ovárico debido a mecanismos desconocidos.
  • Las causas pueden incluir factores genéticos, tratamientos médicos como quimioterapia o radioterapia e intervenciones quirúrgicas.

Objetivo del estudio:

  • Para definir la insuficiencia ovárica primaria (POI) y sus causas subyacentes.
  • Para delinear los criterios de diagnóstico para POI.
  • Discutir las implicaciones reproductivas y de salud a largo plazo de POI.

Principales métodos:

  • Revisión de la literatura existente sobre la insuficiencia ovárica primaria.
  • Análisis de marcadores de diagnóstico, incluidos los niveles de hormona folículo estimulante (FSH) y estradiol.
  • Examen del impacto de POI en la fertilidad y la salud general de las mujeres.

Principales resultados:

  • La IOP se diagnostica por la ausencia de ciclos menstruales y se confirma por el aumento de la FSH sérica y la disminución del estradiol.
  • La condición con frecuencia conduce a la esterilidad, afectando significativamente la salud reproductiva, especialmente en individuos jóvenes.
  • La deficiencia de estrógenos a largo plazo plantea riesgos para la densidad ósea, la salud cardiovascular, la función neurológica y el bienestar general.

Conclusiones:

  • La insuficiencia ovárica primaria requiere un diagnóstico y un tratamiento cuidadosos debido a sus profundos efectos en la capacidad reproductiva.
  • Se deben considerar opciones de preservación de la fertilidad para las personas en riesgo, incluidos los pacientes con cáncer y aquellos con antecedentes familiares de POI.
  • Abordar las consecuencias a largo plazo para la salud de la privación de estrógenos es crucial para el manejo de pacientes con POI.